Lithium augmentation in the treatment of bipolar depression;Lithiumaugmentation zur behandlung der bipolaren depression

PsychoNeuro

Volumn 29, Issue 9, 2003, Pages 392-399

  Bschor, Tom ^a   Lewitzka, Ute ^b   Bauer, Michael ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b NONE

Author keywords

Antidepressant; Bipolar depression; Lithium augmentation; Refractory depression; Switch into mania

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; DEXTROMETHORPHAN; KETAMINE; LITHIUM; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; MANIA; MONOTHERAPY; PROPHYLAXIS; RISK BENEFIT ANALYSIS; SHORT SURVEY; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0141926680     PISSN: 16119991     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43141     Document Type: Short Survey

References (15)

1. Adli M, Bschor T, Canata B, Döpfmer S, Bauer M. Lithium in der Behandlung der akuten Depression. Fortschr Neurol Psychiat 1998; 66: 435-441
2. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (second edition). American Psychiatric Publishing, Inc., Washington, DC, 2002
3. Bauer M, Döpfmer S. Lithium augmentation in treatment-resistant depression - A meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 1999; 19: 427-434
4. Bauer M, Forsthoff A, Baethge C, Adli M, Berghöfer A, Döpfmer S, Bschor T. Lithium augmentation therapy in refractory depression - Update 2002. Eur Arch Psychiatry Clin Neurosci 2003; 253: 132-139
5. Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for biological treatment of unipolar depressive disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatr 2002; 3: 5-43
6. Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders, Part 2: Maintenance Treatment of Major Depressive Disorder & Treatment of Chronic Depressive Disorders and Subthreshold Depressions. World J Biol Psychiatr 2002; 3: 69-86
7. Berghöfer A, Adli M, Baethge C, Bauer M, Bschor T, Müller-Oerlinghausen B, Schäfer M, Willich S. Phasenprophylaxe. In: Deutsche Gesellschaft für Bipolare Störungen e. V. (Hg.) Weißbuch Bipolare Störungen in Deutschland. Hamburg, ConferencePoint Verlag, 2003: S. 131-200
8. Bottlender R, Rudolf D, Strauss A, Möller HJ. Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J Affect Disord 2001; 63: 79-83
9. Bschor T, Canata B, Müller-Oerlinghausen B, Bauer M. Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression. J Affect Disorders 2001; 64: 261-265
10. Möller HJ, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 2000; 250: 57-68
11. Montigny de C, Grunberg F, Mayer A, Deschenes JP. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 1981; 138: 252-256
12. Müller-Oerlinghausen B, Berghöfer A, Bauer M. Bipolar disorder. Lancet 2002; 359: 241-247
13. Nelson JC, Mazure CM. Lithium augmentation in psychotic depression refractory to combined d rug treatment. Am J Psychiatry 1986; 143: 363-366
14. Rybakowski J, Matkowski K. Adding lithium to antidepressant therapy: factors related to therapeutic potentiation. Eur Neuropsychopharmacol 1992; 2: 161-165
15. Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996; 16 (Suppl 1): 32-47